The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of TA111): a systematic review and economic model

Mary Bond; Gabriel Rogers; Jaime Peters; Rob Anderson; Martin Hoyle; Alec Miners; Tiffany Moxham; Sarah Davis; Praveen Thokala; Allan Wailoo; Mike Jeffreys; Chris Hyde

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of TA111): a systematic review and economic model

Mary Bond , Gabriel Rogers, Jaime Peters, Rob Anderson, Martin Hoyle, Alec Miners, Tiffany Moxham, Sarah Davis, Praveen Thokala, Allan Wailoo, Mike Jeffreys, Chris Hyde

Research output: Book/Report › Commissioned report

Original language	English
Publisher	University of Exeter
Commissioning body	National Institute for Health and Care Excellence (NICE)
Number of pages	403
Publication status	Published - 2010
Externally published	Yes

Access to Document

https://www.nice.org.uk/guidance/ta217/documents/alzheimers-disease-donepezil-galantamine-rivastigmine-and-memantine-review-a-systematic-review-and-economic-model-a2

Cite this

Bond , M., Rogers, G., Peters, J., Anderson, R., Hoyle, M., Miners, A., Moxham, T., Davis, S., Thokala, P., Wailoo, A., Jeffreys, M., & Hyde, C. (2010). The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of TA111): a systematic review and economic model . University of Exeter. https://www.nice.org.uk/guidance/ta217/documents/alzheimers-disease-donepezil-galantamine-rivastigmine-and-memantine-review-a-systematic-review-and-economic-model-a2

@book{bd2f94a7cce241728752101e8fdbfd59,

title = "The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer{\textquoteright}s disease (review of TA111): a systematic review and economic model ",

author = "Mary Bond and Gabriel Rogers and Jaime Peters and Rob Anderson and Martin Hoyle and Alec Miners and Tiffany Moxham and Sarah Davis and Praveen Thokala and Allan Wailoo and Mike Jeffreys and Chris Hyde",

year = "2010",

language = "English",

publisher = "University of Exeter",

}

Bond , M, Rogers, G, Peters, J, Anderson, R, Hoyle, M, Miners, A, Moxham, T, Davis, S, Thokala, P, Wailoo, A, Jeffreys, M & Hyde, C 2010, The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of TA111): a systematic review and economic model . University of Exeter. <https://www.nice.org.uk/guidance/ta217/documents/alzheimers-disease-donepezil-galantamine-rivastigmine-and-memantine-review-a-systematic-review-and-economic-model-a2>

TY - BOOK

T1 - The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of TA111)

T2 - a systematic review and economic model

AU - Bond , Mary

AU - Rogers, Gabriel

AU - Peters, Jaime

AU - Anderson, Rob

AU - Hoyle, Martin

AU - Miners, Alec

AU - Moxham, Tiffany

AU - Davis, Sarah

AU - Thokala, Praveen

AU - Wailoo, Allan

AU - Jeffreys, Mike

AU - Hyde, Chris

PY - 2010

Y1 - 2010

M3 - Commissioned report

BT - The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of TA111)

PB - University of Exeter

ER -